Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitisBianca Woehrl, Diederik van de Beek, Matthijs C. Brouwer et al.|Journal of Clinical Investigation|2011Cited by 129
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease modelsSarah M. Carpanini, B. Paul Morgan|Acta Neuropathologica Communications|2022Cited by 97
The complement system in neurodegenerative diseasesJacqui Nimmo, B. Paul Morgan, Robert A.J. Byrne et al.|Clinical Science|2024Cited by 48
Complement receptor 1 is expressed on brain cells and in the human brainNikoleta Daskoulidou, B. Paul Morgan|Glia|2023Cited by 34